Herve R. Bonnefoi
Advanced in Menopause

Herve R. Bonnefoi

Bordeaux, FR 
Advanced in Menopause
Bordeaux, FR 
OverviewLocationsClinical Research

Overview

Herve Bonnefoi practices in Bordeaux, France. Mr. Bonnefoi is rated as an Advanced expert by MediFind in the treatment of Menopause. His top areas of expertise are Breast Cancer, HER2 Negative Breast Cancer, Menopause, Febrile Neutropenia, and Mastectomy.

His clinical research consists of co-authoring 127 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 13 articles in the study of Menopause.

Gender
Male

Locations

Bordeaux, France
Other Locations
229 Cours De L'Argonne, F-33000 Bordeaux, France [2] INSERM U916, 229 Cours De L'Argonne, F-33000 Bordeaux, 16 Avenue Léon Duguit, F-33608 Pessac, 146, Rue Léo Saignat, F-33076 Bordeaux, France [5] CNRS UMR5800, 351 Cours De La Libération, Talence, 33405, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

PERSONALIZED MEDICINE GROUP / UCBG UC-0105/1304: SAFIR02_Breast - Evaluation of the Efficacy of High Throughput Genome Analysis as a Therapeutic Decision Tool for Patients With Metastatic Breast Cancer
PERSONALIZED MEDICINE GROUP / UCBG UC-0105/1304: SAFIR02_Breast - Evaluation of the Efficacy of High Throughput Genome Analysis as a Therapeutic Decision Tool for Patients With Metastatic Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: January 15, 2025
Intervention Type: Drug
Study Drugs: AZD2014, AZD4547, AZD5363, AZD8931, Selumetinib, Vandetanib, Bicalutamide, Olaparib, Anthracyclines, Taxanes, Cyclophosphamide, DNA Intercalators, Methotrexate, Vinca Alkaloids, Platinum Based Chemotherapies, Bevacizumab, Mitomycin C, Eribulin, MEDI4736
Study Phase: Phase 2
A Phase Ib/II Trial Evaluating the Efficacy of MK-3475 and Trastuzumab in Patients With Trastuzumab-resistant, HER2-positive Metastatic Breast Cancers
A Phase Ib/II Trial Evaluating the Efficacy of MK-3475 and Trastuzumab in Patients With Trastuzumab-resistant, HER2-positive Metastatic Breast Cancers
Enrollment Status: Completed
Publish Date: February 15, 2019
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
View 1 Less Clinical Trial

127 Total Publications

Assessment of Adjuvant Endocrine Therapy With Ovarian Function Suppression by Breast Cancer Index.
Assessment of Adjuvant Endocrine Therapy With Ovarian Function Suppression by Breast Cancer Index.
Journal: JAMA network open
Published: November 03, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Bonnefoi's expertise for a condition
ConditionClose
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile